These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35212439)

  • 1. Expanded carrier screening in the United States: A systematic evidence review exploring client and provider experiences.
    Ramdaney A; Lichten L; Propst L; Mann C; Lazarin GA; Jones M; Taylor A; Malinowski J
    J Genet Couns; 2022 Aug; 31(4):937-948. PubMed ID: 35212439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interest in expanded carrier screening among individuals and couples in the general population: systematic review of the literature.
    Van Steijvoort E; Chokoshvili D; W Cannon J; Peeters H; Peeraer K; Matthijs G; Borry P
    Hum Reprod Update; 2020 Apr; 26(3):335-355. PubMed ID: 32099997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded carrier screening for reproductive risk assessment: An evidence-based practice guideline from the National Society of Genetic Counselors.
    Sagaser KG; Malinowski J; Westerfield L; Proffitt J; Hicks MA; Toler TL; Blakemore KJ; Stevens BK; Oakes LM
    J Genet Couns; 2023 Jun; 32(3):540-557. PubMed ID: 36756860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.
    Capalbo A; Fabiani M; Caroselli S; Poli M; Girardi L; Patassini C; Favero F; Cimadomo D; Vaiarelli A; Simon C; Rienzi LF; Ubaldi FM
    Hum Reprod; 2021 Jun; 36(7):2050-2061. PubMed ID: 34021342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal genetic carrier screening in the genomic age.
    Gregg AR; Edwards JG
    Semin Perinatol; 2018 Aug; 42(5):303-306. PubMed ID: 30241949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes of the general population towards preconception expanded carrier screening for autosomal recessive disorders including inborn errors of metabolism.
    Nijmeijer SCM; Conijn T; Lakeman P; Henneman L; Wijburg FA; Haverman L
    Mol Genet Metab; 2019 Jan; 126(1):14-22. PubMed ID: 30563741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnant Women's Perspectives on Expanded Carrier Screening.
    Propst L; Connor G; Hinton M; Poorvu T; Dungan J
    J Genet Couns; 2018 Sep; 27(5):1148-1156. PubMed ID: 29476298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconception expanded carrier screening: Impact of information presented by text or video on genetic knowledge and attitudes.
    Conijn T; Nijmeijer SCM; Lakeman P; Henneman L; Wijburg FA; Haverman L
    J Genet Couns; 2021 Apr; 30(2):457-469. PubMed ID: 32940388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and post-testing counseling considerations for the provision of expanded carrier screening: exploration of European geneticists' views.
    Janssens S; Chokoshvili D; Vears DF; De Paepe A; Borry P
    BMC Med Ethics; 2017 Aug; 18(1):46. PubMed ID: 28764782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded carrier screening for recessively inherited disorders: economic burden and factors in decision-making when one individual in a couple is identified as a carrier.
    Shapiro AJ; Kroener L; Quinn MM
    J Assist Reprod Genet; 2021 Apr; 38(4):957-963. PubMed ID: 33501564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opening Pandora's box: abnormal genetic carrier screening and need for lifetime follow-up.
    Strauss TS; Boniferro E; Brockhoff E; Johnson A; Schneider E; Grubman O; Cole D; Hussain F; Ashmead G; Al-Ibraheemi Z; Brustman L
    Am J Obstet Gynecol MFM; 2023 Mar; 5(3):100820. PubMed ID: 36455867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanded genetic carrier screening in clinical practice: a current survey of patient impressions and attitudes.
    Pereira N; Wood M; Luong E; Briggs A; Galloway M; Maxwell RA; Lindheim SR
    J Assist Reprod Genet; 2019 Apr; 36(4):709-716. PubMed ID: 30761454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic analysis of online marketing materials used by providers of expanded carrier screening.
    Chokoshvili D; Borry P; Vears DF
    Genet Med; 2018 Sep; 20(9):976-984. PubMed ID: 29240075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to completion of expanded carrier screening in an inner city population.
    Strauss TS; Schneider E; Boniferro E; Brockhoff E; Johnson A; Stoffels G; Feldman K; Grubman O; Cole D; Hussain F; Ashmead G; Al-Ibraheemi Z; Brustman L
    Genet Med; 2023 Jul; 25(7):100858. PubMed ID: 37087636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel.
    Stevens B; Krstic N; Jones M; Murphy L; Hoskovec J
    Obstet Gynecol; 2017 Aug; 130(2):279-284. PubMed ID: 28697118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnant Latinas' perspectives on pursuing expanded carrier screening: "It is better to know than not".
    Tedross M; Wang H; Heigl-Maza C; Russell R; Young C; Kramer J; Martinez D; Chen WJ; Robbins-Furman P; Page R; Montalvo-Liendo N; Chen LS
    J Genet Couns; 2023 Aug; 32(4):887-895. PubMed ID: 36949635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Expanded Carrier Screening in Reproductive Medicine: Scientific Impact Paper No. 74.
    Elson J; Drakeley A; Achilli C; Canham N; Kulke C;
    BJOG; 2024 Sep; 131(10):e81-e85. PubMed ID: 38839259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does carrier status for recessive disorders influence reproductive decisions? A systematic review of the literature.
    Cannon J; Van Steijvoort E; Borry P; Chokoshvili D
    Expert Rev Mol Diagn; 2019 Dec; 19(12):1117-1129. PubMed ID: 31709839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.